F Lamothe

1.9k total citations
48 papers, 1.4k citations indexed

About

F Lamothe is a scholar working on Epidemiology, Infectious Diseases and Clinical Biochemistry. According to data from OpenAlex, F Lamothe has authored 48 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Epidemiology, 18 papers in Infectious Diseases and 10 papers in Clinical Biochemistry. Recurrent topics in F Lamothe's work include Bacterial Identification and Susceptibility Testing (10 papers), HIV, Drug Use, Sexual Risk (10 papers) and HIV/AIDS Research and Interventions (9 papers). F Lamothe is often cited by papers focused on Bacterial Identification and Susceptibility Testing (10 papers), HIV, Drug Use, Sexual Risk (10 papers) and HIV/AIDS Research and Interventions (9 papers). F Lamothe collaborates with scholars based in Canada, Niger and France. F Lamothe's co-authors include Julie Bruneau, L P Jetté, Jean Vincelette, Eduardo L. Franco, Nicolas Lachance, Christiane Gaudreau, Anne–Marie Bourgault, Marie Désy, M. Develoux and Bertrand Sellin and has published in prestigious journals such as Gastroenterology, Clinical Infectious Diseases and American Journal of Epidemiology.

In The Last Decade

F Lamothe

48 papers receiving 1.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
F Lamothe Canada 21 849 532 372 176 156 48 1.4k
Caroline C. Johnson United States 19 475 0.6× 608 1.1× 206 0.6× 298 1.7× 124 0.8× 34 1.5k
A A Hoosen South Africa 27 897 1.1× 697 1.3× 213 0.6× 71 0.4× 669 4.3× 115 2.0k
Birgit van Benthem Netherlands 28 946 1.1× 836 1.6× 378 1.0× 85 0.5× 362 2.3× 94 2.0k
Tahaniyat Lalani United States 21 750 0.9× 884 1.7× 363 1.0× 257 1.5× 73 0.5× 88 1.6k
Richard Brindle United Kingdom 24 1.3k 1.5× 1.3k 2.5× 326 0.9× 222 1.3× 72 0.5× 46 2.1k
Davis Mwakagile Tanzania 19 468 0.6× 868 1.6× 232 0.6× 73 0.4× 69 0.4× 36 2.0k
Hsin–Chun Lee Taiwan 19 484 0.6× 492 0.9× 178 0.5× 74 0.4× 62 0.4× 48 1.1k
Jean Vincelette Canada 25 1.1k 1.3× 885 1.7× 389 1.0× 70 0.4× 98 0.6× 72 2.1k
Kamal Hamed United States 29 978 1.2× 816 1.5× 562 1.5× 179 1.0× 154 1.0× 117 2.2k
Gabriela Echániz-Avilés Mexico 24 1.1k 1.3× 579 1.1× 571 1.5× 177 1.0× 571 3.7× 89 1.9k

Countries citing papers authored by F Lamothe

Since Specialization
Citations

This map shows the geographic impact of F Lamothe's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by F Lamothe with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites F Lamothe more than expected).

Fields of papers citing papers by F Lamothe

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by F Lamothe. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by F Lamothe. The network helps show where F Lamothe may publish in the future.

Co-authorship network of co-authors of F Lamothe

This figure shows the co-authorship network connecting the top 25 collaborators of F Lamothe. A scholar is included among the top collaborators of F Lamothe based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with F Lamothe. F Lamothe is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Bruneau, Julie, Mark Daniel, Michał Abrahamowicz, et al.. (2011). Trends in Human Immunodeficiency Virus Incidence and Risk Behavior Among Injection Drug Users in Montreal, Canada: A 16-Year Longitudinal Study. American Journal of Epidemiology. 173(9). 1049–1058. 52 indexed citations
2.
Brogly, Susan B., Julie Bruneau, Jean Vincelette, F Lamothe, & Eduardo L. Franco. (2000). Risk behaviour change and HIV infection among injection drug users in Montreal. AIDS. 14(16). 2575–2582. 16 indexed citations
3.
Bruneau, Julie, F Lamothe, Eduardo L. Franco, et al.. (1997). High Rates of HIV Infection among Injection Drug Users Participating in Needle Exchange Programs in Montreal: Results of a Cohort Study. American Journal of Epidemiology. 146(12). 994–1002. 213 indexed citations
4.
Scott, J. Anthony G., Andy Hall, Ron Dagan, et al.. (1996). Serogroup-Specific Epidemiology of Streptococcus pneumoniae: Associations with Age, Sex, and Geography in 7,000 Episodes of Invasive Disease. Clinical Infectious Diseases. 22(6). 973–981. 173 indexed citations
5.
Lamothe, F, et al.. (1995). Clinical Usefulness of Intravenous Human Immunoglobulins in Invasive Group A Streptococcal Infections: Case Report and Review. Clinical Infectious Diseases. 21(6). 1469–1470. 88 indexed citations
6.
Turgeon, Patricia, et al.. (1994). Longitudinal study of susceptibilities of species of the Bacteroides fragilis group to five antimicrobial agents in three medical centers. Antimicrobial Agents and Chemotherapy. 38(10). 2276–2279. 26 indexed citations
7.
Gaudreau, Christiane & F Lamothe. (1992). Campylobacter upsaliensis isolated from a breast abscess. Journal of Clinical Microbiology. 30(5). 1354–1356. 21 indexed citations
8.
Bourgault, Anne–Marie, F Lamothe, D. J. Hoban, et al.. (1992). Survey of Bacteroides fragilis group susceptibility patterns in Canada. Antimicrobial Agents and Chemotherapy. 36(2). 343–347. 41 indexed citations
9.
Lamothe, F, et al.. (1992). Needle sharing behaviour among injection drug users (IDUs) in treatment in Montreal and Toronto, 1988-1989.. PubMed. 83(1). 38–41. 12 indexed citations
10.
Develoux, M., et al.. (1991). Human hydatidosis in Niger.. PubMed. 94(6). 423–4. 5 indexed citations
11.
Poirier, Lionel A., F Lamothe, Jean Vincelette, & Anne–Marie Bourgault. (1991). Usefulness of semi-quantitative cultures in the diagnosis ofClostridium difficile associated disease. European Journal of Clinical Microbiology & Infectious Diseases. 10(9). 770–772. 3 indexed citations
12.
Gaudreau, Christiane, et al.. (1991). Role of the beta-lactamase of Campylobacter jejuni in resistance to beta-lactam agents. Antimicrobial Agents and Chemotherapy. 35(5). 813–818. 53 indexed citations
13.
Lamothe, F, et al.. (1990). [Value of echography in the study of periportal fibrosis caused by schistosomiasis in an endemic African zone].. PubMed. 33(1). 44–7. 4 indexed citations
14.
Develoux, M., et al.. (1987). [A case of hydatid cyst of the mediastinum in the Republic of Niger].. PubMed. 46(4). 401–4. 2 indexed citations
15.
Cénac, A, et al.. (1987). Delta superinfection in patients with chronic hepatitis, liver cirrhosis and hepatocellular carcinoma in a Sahelian area. Study of 112 cases versus 46 controls. Transactions of the Royal Society of Tropical Medicine and Hygiene. 81(6). 994–997. 4 indexed citations
16.
Horn, R, Anne–Marie Bourgault, & F Lamothe. (1987). Disk diffusion susceptibility testing of the Bacteroides fragilis group. Antimicrobial Agents and Chemotherapy. 31(10). 1596–1599. 21 indexed citations
17.
Bourgault, Anne–Marie, G. K. M. Harding, John A. Smith, et al.. (1986). Survey of anaerobic susceptibility patterns in Canada. Antimicrobial Agents and Chemotherapy. 30(5). 798–801. 40 indexed citations
18.
Malouin, François, et al.. (1986). Inactivation of cefoxitin and moxalactam by Bacteroides bivius beta-lactamase. Antimicrobial Agents and Chemotherapy. 30(5). 749–755. 7 indexed citations
19.
Lamothe, F, et al.. (1984). Serogroups and serotypes of pneumococci in Montreal: correlations with age, outcome and indications for vaccination.. PubMed. 130(6). 737–40. 11 indexed citations
20.
Lacroix, Jacques, F Lamothe, & François Malouin. (1984). Role of Bacteroides bivius beta-lactamase in beta-lactam susceptibility. Antimicrobial Agents and Chemotherapy. 26(5). 694–698. 18 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Caroline C. Johnson Breakdown of academic impact, for papers by A A Hoosen Breakdown of academic impact, for papers by Birgit van Benthem Breakdown of academic impact, for papers by Tahaniyat Lalani Breakdown of academic impact, for papers by Richard Brindle Breakdown of academic impact, for papers by Davis Mwakagile Breakdown of academic impact, for papers by Hsin–Chun Lee Breakdown of academic impact, for papers by Jean Vincelette Breakdown of academic impact, for papers by Kamal Hamed Breakdown of academic impact, for papers by Gabriela Echániz-Avilés
Rankless by CCL
2026